MaxCyte, Inc. STX Scalable Transfection System for Cell-Based Assays in Drug Discovery: Screening Data to Be Presented at the 15th Annual SBS Meeting in Lille, France

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, will feature the MaxCyte® STX™ Scalable Transfection System at booth 285 at the Society for Biomolecular Sciences (SBS) 15th Annual Conference & Exhibition in Lille, France, April 26-30. The MaxCyte STX is a valuable tool for drug discovery groups to reduce the timeline for the development of biologically relevant cell-based assays and to accelerate the screening of compound libraries for drug candidate selection.